A new study reveals that adults diagnosed with type 1 diabetes face a heightened risk of cardiovascular disease and death, with no better prognosis than those diagnosed in childhood.
A major clinical trial has found that low-dose interleukin-2 (IL2LD) is safe and may significantly extend survival in people with motor neurone disease (ALS).
A neuroscience mystery has been solved by using artificial intelligence (AI) to identify the electrical signatures of different types of brain neurons for the first time.
A new study by the University of Manchester has found that a new clotbusting drug is significantly better at treating ischemic stroke than existing treatments.
Dr Sung Min Son and Prof David Rubinsztein (UK DRI at Cambridge) have identified a key enzyme driving forms of Parkinson’s disease, highlighting a promising new target for treatment.
New evidence shows female genital mutilation is increasingly being carried out by health workers, with one in four girls undergoing the procedure at their hands.
The first comprehensive analysis of three major lung diseases, asthma, chronic obstructive pulmonary disease (COPD), and interstitial lung disease (ILD), across England, Wales, Scotland, and Northern Ireland has been published.
